BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1951724)

  • 41. Coronary microvascular response to endothelin is dependent on vessel diameter and route of administration.
    Lamping KG; Clothier JL; Eastham CL; Marcus ML
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H703-9. PubMed ID: 1415594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo effects of endothelin-2, endothelin-3 and ETA receptor blockade on arterial, venous and capillary functions in cat skeletal muscle.
    Ekelund U
    Acta Physiol Scand; 1994 Jan; 150(1):47-56. PubMed ID: 8135123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of endothelin-1 on arterial pressure and myocardial contractility in the conscious normotensive rabbit.
    Roberts-Thomson P; McRitchie RJ; Chalmers JP
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):315-8. PubMed ID: 2065476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of low perfusion pressure on effect of endothelin on coronary vascular bed.
    Clozel JP; Sprecher U
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H893-901. PubMed ID: 2000984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans.
    Pernow J; Kaijser L; Lundberg JM; Ahlborg G
    Circulation; 1996 Nov; 94(9):2077-82. PubMed ID: 8901654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cumulative doses of NG-nitro-L-arginine methyl ester on coronary blood flow of anesthetized and conscious dogs.
    Matsunaga T; Okumura K; Ishizaka H; Tsunoda R; Yasue H
    Arch Int Pharmacodyn Ther; 1994; 327(3):251-65. PubMed ID: 7848010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determinants of coronary effects of atrial natriuretic factor in dogs.
    Ertl G; Bauer B; Gaudron P; Kolb M; Kochsiek K
    Eur J Clin Invest; 1992 Aug; 22(8):516-22. PubMed ID: 1425857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition.
    Holtz J; Förstermann U; Pohl U; Giesler M; Bassenge E
    J Cardiovasc Pharmacol; 1984; 6(6):1161-9. PubMed ID: 6084775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effects of endothelin and Bay k 8644 on cardiohemodynamics in anesthetized pigs.
    Adachi H; Shoji T; Goto K
    Eur J Pharmacol; 1991 Jan; 193(1):57-65. PubMed ID: 1710988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of mibefradil on large and small coronary arteries in conscious dogs: role of vascular endothelium.
    Karila-Cohen D; Dubois-Randé JL; Giudicelli JF; Berdeaux A
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):271-7. PubMed ID: 8856484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adrenergic coronary vasoconstriction in acute right ventricular hypertension.
    Gold FL; Horwitz LD; Bache RJ
    Cardiovasc Res; 1984 Jul; 18(7):447-54. PubMed ID: 6744366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans.
    Crossman DC; Larkin SW; Fuller RW; Davies GJ; Maseri A
    Circulation; 1989 Sep; 80(3):475-84. PubMed ID: 2475277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential relaxant effect of high concentrations of intravenous anesthetics on endothelin-constricted proximal and distal canine coronary arteries.
    Coughlan MG; Flynn NM; Kenny D; Warltier DC; Kampine JP
    Anesth Analg; 1992 Mar; 74(3):378-83. PubMed ID: 1539819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of verapamil and nitroglycerin on coronary and systemic hemodynamics in conscious dogs.
    Adachi H; Tomoike H; Nishijima H; Hayashi Y; Yamada A; Nakamura M
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1072-8. PubMed ID: 3110406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelin does not interact with angiotensin II in the coronary vascular bed of anesthetized dogs.
    Kiss P; Horváth I; Szokodi I; Tóth P; Kékesi V; Juhász-Nagy A; Tóth M
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S103-5. PubMed ID: 9595412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bradykinin suppresses endothelin-induced contraction of coronary, renal and femoral arteries through its B2-receptor on the endothelium.
    Ohde H; Morimoto S; Ohnishi K; Yamaoka E; Fukuo K; Yasuda O; Ogihara T
    Agents Actions Suppl; 1992; 38 ( Pt 3)():14-22. PubMed ID: 1334347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of long-term nicorandil application on coronary arteries in conscious dogs.
    Huckstorf C; Bassenge E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S29-33. PubMed ID: 1282173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous adenosine modulates alpha 2- but not alpha 1-adrenergic constriction of coronary arterioles.
    DeFily DV; Patterson JL; Chilian WM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2487-94. PubMed ID: 7611499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reflex epicardial coronary vasoconstriction elicited by nicotine in anaesthetized dogs.
    Sobey CG; Dusting GJ; Woodman OL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):464-8. PubMed ID: 2567966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of endothelin on renal hemodynamics and renal function in anesthetized dogs.
    Miura K; Yukimura T; Yamashita Y; Shichino K; Shimmen T; Saito M; Okumura M; Imanishi M; Yamanaka S; Yamamoto K
    Am J Hypertens; 1990 Aug; 3(8 Pt 1):632-4. PubMed ID: 2222955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.